跳至主要内容
临床试验/NCT06217562
NCT06217562已完成4 期

Vasopressin for Septic Shock Pragmatic Trial

Intermountain Health Care, Inc.26 个研究点 分布在 1 个国家目标入组 3,959 人开始时间: 2024年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
3,959
试验地点
26
主要终点
28-day all-cause mortality

研究概览

简要总结

Life-threatening low blood pressure due to a serious infection is called "septic shock." Septic shock is treated with vasopressors, medications that raise blood pressure. Sometimes first-line vasopressors are inadequate, prompting addition of a second-line vasopressor called vasopressin. However, the threshold at which to start vasopressin remains unclear. This pragmatic, cluster-randomized, cluster-crossover trial will evaluate two different strategies for septic shock treatment commonly used in current practice, comparing a lower versus a higher threshold for adding vasopressin to first-line vasopressors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Admitted to a study hospital emergency department (ED) or inpatient care unit
  • Administration of vasopressor(s) for septic shock

排除标准

  • 未提供

研究组 & 干预措施

Septic shock treatment strategy involving a lower threshold for vasopressin initiation

Active Comparator

Recommended strategy for treatment of septic shock includes initiation of fixed-dose IV vasopressin (1.8 units/hour) as a second-line vasopressor if the combined norepinephrine-equivalent dose of other vasopressors reaches ≥0.1 micrograms/kilogram/minute (mcg/kg/min). Use of the recommended treatment strategy (via entry of an order for threshold-based vasopressin initiation) or an alternative treatment strategy is at the discretion of patients' treating clinical team.

干预措施: Vasopressin (Drug)

Septic shock treatment strategy involving a higher threshold for vasopressin initiation

Active Comparator

Recommended strategy for treatment of septic shock includes initiation of fixed-dose IV vasopressin (1.8 units/hour) as a second-line vasopressor if the combined norepinephrine-equivalent dose of other vasopressors reaches ≥0.4 mcg/kg/min. Use of the recommended treatment strategy (via entry of an order for threshold-based vasopressin initiation) or an alternative treatment strategy is at the discretion of patients' treating clinical team.

干预措施: Vasopressin (Drug)

Septic shock treatment strategy involving a lower threshold for vasopressin initiation

Active Comparator

Recommended strategy for treatment of septic shock includes initiation of fixed-dose IV vasopressin (1.8 units/hour) as a second-line vasopressor if the combined norepinephrine-equivalent dose of other vasopressors reaches ≥0.1 micrograms/kilogram/minute (mcg/kg/min). Use of the recommended treatment strategy (via entry of an order for threshold-based vasopressin initiation) or an alternative treatment strategy is at the discretion of patients' treating clinical team.

干预措施: Recommendation to use a lower initiation threshold for vasopressin (Other)

Septic shock treatment strategy involving a higher threshold for vasopressin initiation

Active Comparator

Recommended strategy for treatment of septic shock includes initiation of fixed-dose IV vasopressin (1.8 units/hour) as a second-line vasopressor if the combined norepinephrine-equivalent dose of other vasopressors reaches ≥0.4 mcg/kg/min. Use of the recommended treatment strategy (via entry of an order for threshold-based vasopressin initiation) or an alternative treatment strategy is at the discretion of patients' treating clinical team.

干预措施: Recommendation to use a higher initiation threshold for vasopressin (Other)

结局指标

主要结局

28-day all-cause mortality

时间窗: 28 days

Death on or before study day 28

次要结局

  • Renal replacement therapy-free days to day 28(28 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (26)

Loading locations...

相似试验